US IVF Treatment Rebound And APAC Reimbursements Will Drive Recovery
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
28 Jul 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
SEK 202.50
31.5% undervalued intrinsic discount15 Aug
SEK 138.80
1Y
-38.2%7D
1.8%